USFDA completes GMP inspection at Dr. Reddy's Laboratories’ R&D centre

20 Sep 2024 Evaluate

United States Food & Drug Administration (USFDA) has completed a routine Good Manufacturing Practice (GMP) inspection at Dr. Reddy's Laboratories’ R&D centre (Integrated Product Development Organisation or IPDO) in Bachupally, Hyderabad.

The inspection was conducted from September 16, 2024 to September 20, 2024. The inspection closed with zero observations.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Lab Share Price

1194.55 -19.40 (-1.60%)
21-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1777.65
Dr. Reddys Lab 1194.55
Cipla 1465.65
Lupin 2043.30
Zydus Lifesciences 944.25
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.